FDA genehmigt zweites Alzheimer-Medikament, das die Krankheit leicht verlangsamen kann
https://abcnews.go.com/Health/wireStory/fda-approves-alzheimers-drug-modestly-slow-disease-111619103
FDA genehmigt zweites Alzheimer-Medikament, das die Krankheit leicht verlangsamen kann
https://abcnews.go.com/Health/wireStory/fda-approves-alzheimers-drug-modestly-slow-disease-111619103
1 Kommentar
The FDA approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of dementia caused by Alzheimer’s. It’s only the second that’s been convincingly shown to delay cognitive decline in patients, following last year’s approval of a similar from Japanese drugmaker Eisai. This will help bring forward more ways to combat Alzheimer’s and hopefully eventually a full cure for it in the future